haematology

• iron deficiency diagnosis (context-specific thresholds), oral vs. IV repletion, HMB workup, Fishbane reactions, HF evidence
  10 min 2026-04-15
• multiple myeloma plasma cell malignancy, CRAB/SLiM criteria, induction therapy
  6 min 2026-04-01
• acute leukaemia wip AML/ALL/APL recognition, leukostasis, differentiation syndrome, TLS, APL coagulopathy
  7 min 2026-04-15
• antiphospholipid syndrome wip Sapporo criteria, triple positivity, warfarin (not DOACs), CAPS triple therapy, obstetric APS
  4 min 2026-04-15
• deep vein thrombosis wip Wells score, CUS algorithm, DOAC selection (COBRRA), duration by risk category, pregnancy VTE, dose-reduction evidence (API-CAT/RENOVE)
  5 min 2026-04-15
• hereditary thrombophilia wip when (and when not) to test, assay interference (DOACs, inflammation, pregnancy), specific defects, prophylaxis in pregnancy and on hormones
  4 min 2026-04-16
• tumour lysis syndrome wip Cairo-Bishop criteria, risk stratification, rasburicase (dosing, G6PD contraindication, lab artefact), electrolyte management, dialysis indications
  6 min 2026-08-17
• febrile neutropaenia wip 60-minute antibiotic bundle, MASCC risk stratification, antifungal escalation, de-escalation by ANC vs. time-based approach, Duffy null, medication-induced neutropaenia patterns
  9 min 2026-08-10
• superficial vein thrombosis wip SVT management algorithm (proximity to SFJ, thrombus length), CALISTO/SURPRISE evidence, recurrent SVT workup (varicose veins, malignancy, APS, Behçet's), pregnancy SVT
  9 min 2026-08-03
• anaemia wip MCV-based classification, reticulocyte interpretation, iron studies in inflammation, haemolysis workup, transfusion thresholds
  4 min 2026-08-23
• thrombocytopaenia wip pseudothrombocytopaenia exclusion, TTP/HIT/DIC recognition, ITP management, 4T score
  4 min 2026-08-23
• heparin-induced thrombocytopaenia wip 4T score detail, anti-PF4 testing algorithm, argatroban vs fondaparinux vs bivalirudin, warfarin transition, delayed-onset and autoimmune HIT
  7 min 2026-08-23
• periprocedural anticoagulation wip PAUSE protocol for DOACs, BRIDGE trial for warfarin, procedure bleeding risk stratification, neuraxial timing, Thrombosis Canada tools
  5 min 2026-08-23
• anticoagulant reversal wip PCC, idarucizumab, andexanet alfa, protamine; dosing by scenario, when to restart
  5 min 2026-08-23
• DOAC dosing in renal impairment and obesity wip Cockcroft-Gault vs eGFR, CrCl thresholds per agent, dialysis, obesity (ISTH 2021), anti-Xa monitoring
  5 min 2026-08-23

[back to home](/)